Benjamin Cravatt

Benjamin F.
Cravatt is the founder of ActivX Biosciences, Inc., founded in 2000.
Dr. Cravatt was the founder of Abide Therapeutics, Inc., founded in 2011, and served as Director from 2011 to 2019.
Dr. Cravatt is the founder of Vividion Therapeutics, Inc., founded in 2014, and serves as Director since 2014.
Dr. Cravatt is the founder of Belharra Therapeutics, Inc., founded in 2021, and serves as Director since 2021.
Dr. Cravatt was the founder of Boundless Bio, Inc., founded in 2018, and served as Director from 2018 to 2023.
Dr. Cravatt is also the founder of Kisbee Therapeutics, Inc.,Kojin Therapeutics, Inc.,Magnet Biomedicine, Inc...
Dr. Cravatt is currently Director at Inception Sciences, Inc. Dr. Cravatt is currently Director at Sea Pharmaceuticals LLC since 2019.
Dr. Cravatt is currently Director at Autobahn Therapeutics, Inc. since 2020.
Dr. Cravatt is currently Director at Alnylam Pharmaceuticals, Inc. since 2026.
Dr. Cravatt is a Member of the National Academy of Sciences.
Dr. Cravatt is a Member of the American Academy of Arts & Sciences.
Dr. Cravatt is a Member of the National Academy of Medicine (United States).
Dr. Cravatt is a Member of the National Academy of Inventors.
Dr. Cravatt was Independent Director at Kyntra Bio, Inc. from 2020 to 2024.
Dr. Cravatt was Professor at The Scripps Research Institute.
Dr. Cravatt was Advisor at 5AM Venture Management LLC in 2010.
Dr. Cravatt completed undergraduate education at Stanford University.
Dr. Cravatt earned a doctorate from The Scripps Research Institute in 1996.